Addiction & Criminology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Addiction & Criminology (2024) Volume 7, Issue 2

Understanding co-occurring mental health and substance use disorders.

Yasemin Keser *

Department of Psychiatric Nursing, Akdeniz University, Türkiye

*Corresponding Author:
Yasemin Keser
Department of Psychiatric Nursing, Akdeniz University, Türkiye

Received: 02-Apr -2024, Manuscript No. AARA-24-132273; Editor assigned: 03-Apr-2024, PreQC No. AARA-24-132273(PQ); Reviewed:17-Apr-2024, QC No. AARA-24-132273; Revised:22-Apr-2024, Manuscript No. AARA-24-132273 (R); Published:29-Apr-2024, DOI:10.35841/aara-7.2.203

Citation: Keser Y, Understanding co-occurring mental health and substance use disorders. Addict Criminol. 2024;7(2):203

Visit for more related articles at Addiction & Criminology


Co-occurring mental health and substance use disorders, also known as dual diagnosis or comorbidity, refer to the simultaneous presence of a mental health disorder and a substance use disorder in an individual. This complex interplay between mental illness and addiction presents unique challenges in diagnosis, treatment, and recovery. In this article, we delve into the intricacies of co-occurring disorders, their prevalence, common comorbidities, and approaches to integrated treatment [1].

Co-occurring mental health and substance use disorders are prevalent worldwide, affecting individuals of all ages, genders, and socioeconomic backgrounds. Research indicates that approximately 8.9 million adults in the United States experience co-occurring disorders annually, with rates even higher among certain populations, such as veterans, individuals experiencing homelessness, and those involved in the criminal justice system. Common mental health disorders that co-occur with substance use include depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD), and schizophrenia [2].

The relationship between mental health and substance use disorders is complex and multifaceted, with each condition influencing the other in a bidirectional manner. Individuals with untreated mental illness may turn to drugs or alcohol as a form of self-medication to alleviate symptoms or cope with distressing emotions. Conversely, substance abuse can exacerbate underlying mental health issues, leading to a worsening of symptoms and increased risk of psychiatric crises. This cyclical pattern of self-medication and symptom exacerbation underscores the need for integrated approaches to treatment [3].

Diagnosing and treating co-occurring disorders can be challenging due to overlapping symptoms, stigma, and systemic barriers to care. Many individuals with co-occurring disorders may not receive appropriate treatment for both conditions, leading to poor outcomes and a higher risk of relapse. Additionally, stigma surrounding mental illness and substance abuse may discourage individuals from seeking help or disclosing their symptoms, further complicating the diagnostic process [4].

Integrated treatment, also known as dual diagnosis treatment, involves addressing both mental health and substance use disorders concurrently within a comprehensive and coordinated treatment framework. This approach recognizes the interconnectedness of these disorders and the need for tailored interventions that address the unique needs of each individual. Integrated treatment typically includes a combination of pharmacotherapy, psychotherapy, peer support, and psychosocial interventions delivered by a multidisciplinary team of healthcare professionals [5].

Medication management plays a crucial role in the treatment of co-occurring disorders, particularly for individuals with severe or persistent symptoms. Psychiatric medications, such as antidepressants, mood stabilizers, and antipsychotics, may be prescribed to alleviate symptoms of mental illness and stabilize mood. Medications for substance use disorders, such as opioid agonists, nicotine replacement therapy, and medications for alcohol withdrawal, may also be utilized to support recovery and reduce cravings [6].

Psychotherapy, or talk therapy, is an essential component of integrated treatment for co-occurring disorders. Cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), motivational interviewing (MI), and trauma-informed therapy are among the evidence-based approaches commonly used to address both mental health and substance use issues. These therapies help individuals develop coping skills, identify triggers, challenge negative thought patterns, and build resilience in recovery [7].

Peer support programs, such as Alcoholics Anonymous (AA), Narcotics Anonymous (NA), Dual Recovery Anonymous (DRA), and SMART Recovery, offer valuable support and encouragement to individuals with co-occurring disorders. Peer support can help reduce feelings of isolation, shame, and stigma, and promote a sense of belonging and hope [8].

These mutual aid groups provide a safe and supportive environment for sharing experiences, gaining insight, and learning from others who have faced similar challenges in recovery. Psychosocial interventions, such as case management, vocational rehabilitation, housing assistance, and family therapy, address the broader social and environmental factors that impact recovery from co-occurring disorders [9].

These interventions help individuals build practical skills, access resources, and develop healthy relationships and support networks in their communities. By addressing social determinants of health, psychosocial interventions enhance the effectiveness of treatment and support long-term recovery goals [10].


Co-occurring mental health and substance use disorders present complex challenges that require integrated and comprehensive approaches to diagnosis, treatment, and recovery. By understanding the interconnectedness of these disorders and addressing them concurrently within a holistic framework, individuals can achieve improved outcomes and enhanced quality of life in recovery. Through pharmacotherapy, psychotherapy, peer support, and psychosocial interventions, integrated treatment offers hope and healing for individuals with co-occurring disorders, empowering them to reclaim their health, dignity, and resilience.


  1. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiat Cli North America. 1999;22(2):241-52.
  2. Google Scholar

  3. Volkow ND. Personalizing the treatment of substance use disorders. Am J Psychiatry. 2020;177(2):113-6.
  4. Google Scholar, Cross ref

  5. Hasin DS, O’brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834-51.
  6. Indexed at, Google Scholar, Cross ref

  7. Ciraulo DA, Piechniczek-Buczek J, Iscan EN. Outcome predictors in substance use disorders. Psychiatr Clin. 2003;26(2):381-409.
  8. Indexed at, Google Scholar

  9. Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, Room R, Samokhvalov AV, Scafato E, Trapencieris M, Wiers RW. Defining substance use disorders: do we really need more than heavy use?. Alcohol Alcoholism.2013;48(6):633-40.
  10. Google Scholar

  11. Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav ;27(6):507-15.
  12. Indexed at, Google Scholar

  13. McGovern MP, Carroll KM. Evidence-based practices for substance use disorders. Psychiatric Clin. 2003;26(4):991-1010.
  14. Indexed at, Google Scholar

  15. Smith JP, Book SW. Anxiety and substance use disorders: A review. Psychiatr Times. 2008;25(10):19.
  16. Google Scholar

  17. Robinson SM, Adinoff B. The classification of substance use disorders: Historical, contextual, and conceptual considerations. Behav Sci. 2016;6(3):18.
  18. Google Scholar

  19. Ball SA. Personality traits, problems, and disorders: Clinical applications to substance use disorders. J Res Pers. 2005;39(1):84-102.
  20. Indexed at, Google Scholar, Cross ref

Get the App